The latest research study “Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The global biochips market size reached US$ 16.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.8% during 2023-2028.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Biochips Market Industry Definition and Application:

Biochips are miniature versions of a laboratory designed for functioning in a biological environment, especially inside living organisms. They contain millions of sensor elements or biosensors that act as microreactors to detect a particular analyte like a protein, DNA, enzyme, or antibody. They can perform thousands of biological reactions in a few seconds for drug discovery, single nucleotide polymorphism genotyping, in-vitro diagnostics, gene expression profiling and agricultural biotechnology.

Request for a free sample copy of this report: https://www.imarcgroup.com/biochips-market/requestsample

Biochips Market Trends and Drivers:

The global biochips market is primarily driven by growing investments in the healthcare sector. The onset of the coronavirus disease (COVID-19) pandemic has encouraged several biotechnology and pharmaceutical companies to develop biochips for detecting viral infections and immunological disorders in the human body. Besides this, these chips are widely used in the medical industry to detect cancerous cells in the body and for forming targeted and personalized medicines for cancer treatment. Moreover, several advancements and upgradation in nanotechnology and extensive research and development (R&D) activities that results in the emergence of digital microfluidic biochips are also providing a positive thrust to the market growth.

Biochips Market Segmentation:

The report has segmented the market on the basis on type, application, technology, materials, distribution channel and end user.

Breakup by Product Type:

  • DNA Chip
  • Protein Chip
  • Lab-On-a-Chip
  • Enzyme Chip

Breakup by Fabrication Technique:

  • Microarray
  • Microfluidic

Breakup by Analysis Method:

  • Electrophoresis
  • Luminescence
  • Mass Spectrometry
  • Electrical Signals
  • Magnetism

Breakup by Application:

  • Molecular Analysis
    • Hybridization
    • Protein
    • Immunological
    • Biomolecules
    • Biomarker
    • Others
  • Diagnosis
    • Gene Diagnosis
    • Oncology
    • Inflammatory
    • Others
  • Non-Biological Usage

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostics Centers
  • Academic & Research Institutes
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the Major Biochips Market Key players?

The report provides a detailed analysis of the market leaders, including.

  • Agilent Technologies, Inc.
  • bioMérieux SA
  • Bio-RAD Laboratories, Inc.
  • CapitalBio Corporation
  • Dynamic Biosensors GmbH
  • EMD Millipore Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Thermo Fisher Scientific Inc.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2741&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Website: https://www.imarcgroup.com
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group